TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.9812$ -1.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Actuate Therapeutics, Inc. (ACTU): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/13/2026.

Next report 08/13/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q4 24 · -13.8 % 24 Q1 25 · -23.1 % 25 Q2 25 · 3.2 % 25 Q3 25 · 10.7 % 25 Q4 25 · 25.0 % 25 Q1 26 · -14.3 % 26 Q2 26 · 4.8 % 26

EPS estimate beaten

Full history 4 of 7 quarters (57%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 07/17/2026 ACTUATE THERAPEUTICS, INC. (ACTU): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?